China Universal Asset Management Company’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NRIX
WFA
YIH
WB
PFSRSONJ
AA
PR
CPC
China Universal Asset Management Company's NRIX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Nurix Therapeutics (NRIX) stake by 9.8% in Q2 2026, selling an estimated $30.5K and leaving 16,457 shares worth $399K. The position accounts for 0.02% of the portfolio, ranked #283.
China Universal Asset Management Company first reported a position in NRIX in Q3 2022 and has held it in 16 quarters since. 27 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.
- China Universal Asset Management Company held 16,457 shares of Nurix Therapeutics worth $399K as of Q2 2026.
- China Universal Asset Management Company sold 1,793 Nurix Therapeutics shares in Q2 2026, an estimated $30.5K.
- Nurix Therapeutics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #283 holding.
- China Universal Asset Management Company first reported a position in Nurix Therapeutics in Q3 2022 and has held it in 16 quarters since.
- 27 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.